Rezolute (RZLT) Other Non-Current Assets (2012 - 2026)
Rezolute (RZLT) reported Other Non-Current Assets of $2.4 million for Q1 2026, down 16.48% on a YoY basis from $2.9 million in Q1 2025, and up 1.71% sequentially from $2.4 million in Q4 2025.
Rezolute (RZLT) Other Non-Current Assets (2012 - 2026) Analysis & Trends
Rezolute (RZLT) has 14 years of Other Non-Current Assets data on file, last reported at $2.4 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets fell 16.48% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (down 16.48% YoY), and the FY2025 full-year result was $2.9 million, up 59.14% from the prior year.
- Other Non-Current Assets grew to $2.4 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $5.0 million in Q1 2022 to a low of $148000.0 in Q2 2022.
- A 5-year average of $1.7 million and a median of $1.8 million in 2024 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 41566.67% in 2022, while the deepest fall reached 97.04% in 2022.
- Tracing RZLT's Other Non-Current Assets over 5 years: stood at $148000.0 in 2022, then soared by 213.51% to $464000.0 in 2023, then surged by 510.34% to $2.8 million in 2024, then dropped by 15.18% to $2.4 million in 2025, then climbed by 1.71% to $2.4 million in 2026.
- Business Quant data shows RZLT's Other Non-Current Assets at $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $2.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.44 Mn |
| Dec 31, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.68 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.93 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.84 Mn |
| Dec 31, 2023 | 464,000.00 |
| Sep 30, 2023 | 148,000.00 |
| Jun 30, 2023 | 148,000.00 |
| Mar 31, 2023 | 148,000.00 |
| Dec 31, 2022 | 148,000.00 |
| Sep 30, 2022 | 148,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 5.00 Mn |
| Jun 30, 2021 | 191,000.00 |
| Mar 31, 2021 | 12,000.00 |